FAKTOR-OPTIONSSCHEIN - EVOTEC Share Price

Certificat

DE000SD23RC3

Delayed Deutsche Boerse AG 06:51:43 19/06/2024 pm IST
10.13 EUR +1.71% Intraday chart for FAKTOR-OPTIONSSCHEIN - EVOTEC
Current month+25.44%
1 month+57.84%
Date Price Change
19/24/19 10.13 +1.71%
18/24/18 9.96 +2.36%
17/24/17 9.73 +18.37%
14/24/14 8.22 +4.18%
13/24/13 7.89 +7.93%

Delayed Quote Deutsche Boerse AG

Last update June 19, 2024 at 06:51 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying EVOTEC SE
IssuerLogo Issuer Société Générale Société Générale
WKN SD23RC
ISINDE000SD23RC3
Date issued 20/01/2021
Strike 29.5
Maturity Unlimited
Parity 1 : 1
Emission price 10.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.21
Lowest since issue 2.4
Spread 0.05
Spread %0.49%

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
7.535 EUR
Average target price
20.79 EUR
Spread / Average Target
+175.91%
Consensus